Item 2.02 Results of Operations and Financial Condition.

The information in Item 2.02 of this report (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

On April 18, 2023, Fuse Medical, Inc. (the "Company") issued a press release reporting the financial results of the Company for the year ended December 31, 2022. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit
Number                                    Description
99.1*       Press Release, dated April 18, 2023
104       Cover page Interactive Data File (embedded within the inline XBRL document)



* Filed herewith.



                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses